Estimating Correlation between PFS and OS from Reconstructed Survival Data: A Case Study from Previously Untreated Glioblastoma Multiforme

Author(s)

Gogate A1, Kim I2, Kurt M3
1Bristol Myers Squibb, North Brunswick, NJ, USA, 2Bristol Myers Squibb, Livingston, NJ, USA, 3Bristol Myers Squibb, Princeton, NJ, USA

OBJECTIVES : Surrogate predictors may allow earlier assessment of clinical efficacy when overall survival (OS) requires prolonged follow-up times. This study devised a frequentist approach to cope with the absence of individual-level patient data (IPD) in estimating correlation between progression-free survival (PFS) and OS, and presented a case-study from first-line glioblastoma multiforme (GBM).

METHODS : A literature search for recent randomized controlled trials for newly diagnosed GBM identified 13 studies (n = 5971) published between 2005-2019, 2 of which included only MGMT-methylated and 4 of which included only MGMT-unmethylated patients. For each study, pseudo-IPD was reconstructed using the WebPlotDigitizer version 4.2 after digitizing each endpoint’s Kaplan-Meier curve. Using the pseudo-IPD and the dependent modeling framework proposed by Fleischer et al. (2009), Pearson correlation coefficients between PFS and OS were calculated via rates of time-to-progression, and pre- and post-progression death which were derived by maximum-likelihood estimation. Predictive accuracy of the model was assessed by comparing estimated PFS and OS rates with 95% confidence intervals of the observed PFS and OS rates from the trials.

RESULTS : Of the 13 studies consisting of 37 arms in total, 2 were considered to have high association between the endpoints, 16 were considered to have low association, and the remaining 19 had medium association per the IQWiG criteria. The strength of association depended on treatment, subgroup, and sample size. The sample average of the correlation coefficients across all studies was 0.73 in the intent to treat population, 0.67 in MGMT-methylated population, and 0.68 in the MGMT-unmethylated population. The respective prediction accuracies for PFS and OS were 75% and 80% on average across the evidence base.

CONCLUSIONS : The analyses show a moderate relationship between PFS and OS in the first-line GBM setting. Due to simplifying assumptions in the study (e.g. time-homogeneous hazards), results should be approached with caution.

Conference/Value in Health Info

2021-05, ISPOR 2021, Montreal, Canada

Value in Health, Volume 24, Issue 5, S1 (May 2021)

Code

PCN195

Topic

Clinical Outcomes, Methodological & Statistical Research

Topic Subcategory

Relating Intermediate to Long-term Outcomes

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×